Sarah R Herlofsen

Summary

Affiliation: Institute for Cancer Research
Country: Norway

Publications

  1. pmc Genome-wide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells
    Sarah R Herlofsen
    Institute of Immunology and Norwegian Center for Stem Cell Research, Oslo University Hospital Rikshospitalet, Oslo 0424, Norway
    BMC Genomics 14:105. 2013
  2. ncbi request reprint Brief report: importance of SOX8 for in vitro chondrogenic differentiation of human mesenchymal stromal cells
    Sarah R Herlofsen
    Norwegian Center for Stem Cell Research and Institute of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway
    Stem Cells 32:1629-35. 2014

Detail Information

Publications2

  1. pmc Genome-wide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells
    Sarah R Herlofsen
    Institute of Immunology and Norwegian Center for Stem Cell Research, Oslo University Hospital Rikshospitalet, Oslo 0424, Norway
    BMC Genomics 14:105. 2013
    ..To add to the clinical relevance of our observations, the study is based on primary bone marrow-derived MSCs from four donors, allowing us to investigate inter-individual variations...
  2. ncbi request reprint Brief report: importance of SOX8 for in vitro chondrogenic differentiation of human mesenchymal stromal cells
    Sarah R Herlofsen
    Norwegian Center for Stem Cell Research and Institute of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway
    Stem Cells 32:1629-35. 2014
    ..Neither SOX8 nor SOX9 affect COL10A1 expression, but SOX9 inhibits chondrocyte hypertrophy through inhibition of MMP13 and ALPL expression...